Skip to search formSkip to main contentSkip to account menu

15 ML tirofiban 0.25 MG/ML Injection [Aggrastat]

Known as: Aggrastat 3.75 MG per 15 ML Injection, 15 ML Aggrastat 0.25 MG/ML Injection, Aggrastat 3.75 MG in 15 ML Injection 
National Institutes of Health

Related topics

Related topics

8 relations
AggrastatCitric Acid, AnhydrousInjectionSodium Chloride

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Tirofiban (Aggrastat®) - ein Überblick über die derzeitige Publikations- und Studiensituation
2006
2006
CABG-procedures in patients with pretreatment with the GPIIb/IIIa-rezeptor antagonist Tirofiban (Aggrastat®): Modification of perioperative management?
2001
2001
Notfallmäßige Bypasschirurgie unter Medikation mit Aggrastat® / Emergency Coronary Artery Bypass Surgery After Treatment with Tirofiban (Aggrastat)
16 Patienten, die vom 1/7/99 bis 30/8/2000 mit Aggrastat- oder Heparin-medikation notfallmasig operiert wurden, wurden in dieser… 
2000
2000
Tirofiban (Aggrastat®) - ein Überblick über die derzeitige Publikations- und Studiensituation
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)